Vitamin K for Perioperative Warfarin Management
Purpose
This is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.
Condition
- Patients Anti-coagulated With Warfarin Who Require Surgery
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Warfarin therapy for ≥3 months - Use of home INR testing equipment - Scheduled for a surgical procedure that requires INR ≤ 1.5 (typically achieved with warfarin interruption) - INR ≤ 4 on day 7-10 prior to procedure
Exclusion Criteria
- Surgical procedure does not require INR ≤1.5 (typically achieved with warfarin interruption) - Surgical procedure with a high risk of bleeding or complications (urologic procedures, bronchoscopy, epidural injections, nerve blocks, spinal surgery) - Warfarin therapy for < 3 months - Lack of English language proficiency - Use of a Heartmate II or HVAD left ventricular assist device - Recent thrombotic event (within 3 months) - CHA2DS2-VASc score >6 - INR >4 on day 7-10 prior to procedure - Hypersensitivity to any component of Vitamin K or simple syrup (used in the compounding process)
Study Design
- Phase
- Phase 4
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Standard Warfarin Dosing with Vitamin K |
Patients will receive their standard warfarin dosing before, during, and after their procedure. This is in addition to a one time dose of oral vitamin K pre-procedure. |
|
|
Experimental Loading Warfarin Dosing with Vitamin K |
Patients will receive their standard warfarin dosing before and during their procedure. On the night following the procedure, they will receive a one time loading dose of warfarin (twice their normal dose). Patients will then resume normal dosing of warfarin. This is in addition to a one time dose of oral vitamin K pre-procedure. |
|
Recruiting Locations
Ann Arbor, Michigan 48109
More Details
- Status
- Recruiting
- Sponsor
- University of Michigan
Detailed Description
Historically, warfarin is held for 5 days before a surgical procedure to obtain a safe INR (international normalized ratio) that minimizes bleeding risk. However, there is a strong rationale for continuing warfarin uninterrupted in the perioperative space and giving a one-time vitamin K dose to get a safe INR pre-operatively. This feasibility study will recruit patients who use warfarin and will measure their INR response after receiving a single pre-procedure vitamin K dose. This study will also assess the use of a one-time "loading" dose immediately post-operative to help the INR return to the therapeutic range sooner than continuing with the standard warfarin dosing.